Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case–Control Comparison With Intravenous Rituximab - Université Paris-Est-Créteil-Val-de-Marne
Journal Articles Clinical Lymphoma, Myeloma & Leukemia Year : 2021

Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case–Control Comparison With Intravenous Rituximab

Hugo Rotkopf
  • Function : Author
Michaël Lévy
  • Function : Author
Christiane Copie-Bergman
  • Function : Author
Jehan Dupuis
  • Function : Author
Muriel Verlinde-Carvalho
  • Function : Author
Emmanuel Itti
IMRB - SMCD/"Senescence, Metabolism and Cardiovascular Diseases" [Créteil]
Charlotte Gagniere
  • Function : Author
Karim Belhadj
  • Function : Author
Jenny Tannoury
Fabien Le Bras
  • Function : Author
Iradj Sobhani
  • Function : Author
Corinne Haioun
  • Function : Author
Aurelien Amiot

Domains

Life Sciences [q-bio]
Fichier principal
Vignette du fichier
S2152265020304328.pdf (247.18 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Accord Elsevier CCSD  : Connect in order to contact the contributor

https://hal.u-pec.fr/hal-04395407

Submitted on : Monday, July 22, 2024-2:45:19 PM

Last modification on : Monday, July 22, 2024-2:45:20 PM

Download

Dates and versions

hal-04395407 , version 1 (22-07-2024)

Licence

Attribution - NonCommercial

Identifiers

Elsevier-hosted Accepted Manuscript

Cite

Hugo Rotkopf, Michaël Lévy, Christiane Copie-Bergman, Jehan Dupuis, Muriel Verlinde-Carvalho, et al.. Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case–Control Comparison With Intravenous Rituximab. Clinical Lymphoma, Myeloma & Leukemia, 2021, 21 (1), pp.e32-e38. ⟨10.1016/j.clml.2020.08.014⟩. ⟨hal-04395407⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IMRB UPEC
8 View
4 Download

Altmetric

Share

More